Endo Pharmaceuticals Sues Matrix Laboratories and Mylan
- August 18, 2011
Endo Pharmaceuticals filed suit against Matrix Laboratories and Mylan over three patents related to tetrahydrocarbazole derivatives for use in the treatment of migraines. 8/16, District of Delaware, 1:2011cv00717.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.